Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, VIC 3052, Australia.
Int J Pharm. 2011 Dec 12;421(1):176-82. doi: 10.1016/j.ijpharm.2011.09.022. Epub 2011 Sep 22.
Lipid-based liquid crystalline materials are of increasing interest for use as drug delivery systems. The intricate nanostructure of the reversed bicontinuous cubic (V(2)) and inverse hexagonal (H(2)) liquid crystal matrices have been shown to provide diffusion controlled release of actives of varying size and polarity. In this study, we extend the understanding of release to other self-assembled phases, the micellar cubic phase (I(2)) and inverse micelles (L(2)). The systems are comparable as they were all prepared from the one lipid, glyceryl monooleate (GMO), which sequentially forms all four phases with increasing hexadecane (HD) content in excess water. Phase identity was confirmed by small angle X-ray scattering (SAXS). SAXS data indicated that four mesophases were formed with increasing HD content at 25°C: V(2) phase (Pn3m space group) formed at 0-4% (w/w) HD, H(2) phase formed at 4-25% (w/w) HD, I(2) phase (Fd3m space group) formed at 25-40% (w/w) HD and finally L(2) phase formed at >40% (w/w) HD. Analogous compositions using phytantriol rather than GMO as the core lipid did not produce the I(2) phase, with only V(2) to H(2) to L(2) transitions being apparent with increasing HD concentration. In order to relate the liquid crystal phase structure to drug release rate, in vitro release tests were conducted by incorporating radio-labelled glucose as a model hydrophilic drug into the four GMO-based mesophases. It was found that the drug release followed first-order diffusion kinetics and was fastest from V(2) followed by L(2), H(2), and I(2). Drug release was shown to be significantly faster from bicontinuous cubic phase than the other mesophases, indicating that the state of the water compartments, whether open or closed, has a great influence on the rate of drug release. It is envisioned that liquid crystalline mesophases with slower release characteristics will more likely have potential applications as sustained release drug delivery systems, and hence that the bicontinuous cubic phase is not necessarily the best choice for a sustained release matrix.
脂质基液晶材料因其作为药物传递系统的用途而受到越来越多的关注。已证明复杂的反向双连续立方(V(2))和反六方(H(2))液晶基质的纳米结构为不同大小和极性的活性剂提供了扩散控制的释放。在这项研究中,我们将对其他自组装相(胶束立方相(I(2))和反胶束(L(2)))的释放有更深入的了解。这些系统是可比较的,因为它们都是由一种脂质,甘油单油酸酯(GMO)制备的,随着十六烷(HD)在过量水中含量的增加,它依次形成所有四种相。通过小角 X 射线散射(SAXS)确认相态。SAXS 数据表明,在 25°C 下,随着 HD 含量的增加,形成了四个介晶相:V(2)相(Pn3m 空间群)在 0-4%(w/w)HD 时形成,H(2)相在 4-25%(w/w)HD 时形成,I(2)相(Fd3m 空间群)在 25-40%(w/w)HD 时形成,最后 L(2)相在>40%(w/w)HD 时形成。使用植烷三醇而不是 GMO 作为核心脂质的类似组合物没有产生 I(2)相,只有随着 HD 浓度的增加,V(2)到 H(2)到 L(2)的转变才变得明显。为了将液晶相结构与药物释放速率相关联,通过将放射性标记的葡萄糖作为模型亲水性药物掺入四种 GMO 基介晶相中进行了体外释放试验。结果发现,药物释放遵循一级扩散动力学,从 V(2)释放最快,其次是 L(2)、H(2)和 I(2)。从双连续立方相释放药物的速度明显快于其他介晶相,表明水相的状态(开放或封闭)对药物释放速率有很大影响。可以预见,具有较慢释放特性的液晶介晶相更有可能作为缓释药物传递系统应用,因此,双连续立方相不一定是缓释基质的最佳选择。